Welcome to our dedicated page for VERISIGN INC/CA SEC filings (Ticker: VRSN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on VERISIGN INC/CA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into VERISIGN INC/CA's regulatory disclosures and financial reporting.
Verisign Inc. executive chairman, president, CEO and director D. James Bidzos reported open-market sales of 9,000 shares of Verisign common stock over three trading days in January 2026. The Form 4 shows multiple sale transactions on January 13, 14, and 15 at weighted average prices ranging from $246.1671 to $251.08 per share.
After these sales, Bidzos beneficially owned 412,099.1378 shares of Verisign common stock, held directly. The prices reported for each line item reflect weighted averages for numerous individual trades within narrow intraday price ranges, with the insider indicating a willingness to provide full trade-by-trade detail to regulators on request.
VeriSign executive Thomas C. Indelicarto, EVP, General Counsel & Secretary, reported selling a total of 498 shares of VeriSign common stock on January 13, 2026. The transactions were open-market sales of 332 shares at $248.07 per share and 166 shares at $250.00 per share, both reported as direct ownership sales.
After these transactions, Indelicarto directly held 30,613.0161 shares of VeriSign common stock, according to the filing. The report was filed as a single-person Form 4 and does not list any derivative security transactions.
A shareholder of VRSN filed a Rule 144 notice to sell 4,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $985,360. The filing notes that about 92,700,000 shares of this class were outstanding at the time, providing context for the planned sale. The 4,000 shares were acquired as restricted stock units from the issuer on 09/22/2016.
The document also lists recent sales under a Rule 10b5-1 trading plan for Demetrios James Bidzos, including, for example, 5,000 common shares sold on 01/13/2026 for gross proceeds of $1,240,994.20. Additional plan sales occurred across multiple dates in October, November, and December 2025 in blocks of 2,000 or 5,000 shares with disclosed gross proceeds.
A holder of VRSN common stock, identified as Thomas C. Indelicarto, has filed a notice under Rule 144 to sell 498 common shares through Morgan Stanley Smith Barney LLC on or about 01/13/2026 on the NASDAQ, with an aggregate market value of $123,859.24. The filing notes that 92,700,000 common shares were outstanding. The seller acquired 157 shares as performance shares on 02/15/2024 and 341 shares as restricted stock on 05/15/2024, both from the issuer.
Over the prior three months, the same holder reported several open-market sales of the issuer’s common stock, including 501 shares sold on 12/09/2025 for gross proceeds of $125,285.07 and 332 shares sold on 01/06/2026 for $79,955.56. By signing the notice, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Verisign Inc. executive Thomas C. Indelicarto, EVP, General Counsel & Secretary, reported a small insider sale of common stock. On January 9, 2026, he sold 166 shares of Verisign common stock in an open market transaction coded "S" at a price of $250 per share. After this transaction, he directly beneficially owned 31,111.0161 shares of Verisign common stock.
Thomas C. Indelicarto filed a notice of proposed sale under Rule 144 to sell 166 shares of common stock through Morgan Stanley Smith Barney on NASDAQ, with an approximate sale date of 01/09/2026. The filing lists an aggregate market value of about $41,500 for this planned sale and notes that 92,700,000 common shares were outstanding at the time referenced.
The 166 shares to be sold were acquired as restricted stock from the issuer on 05/15/2024, with the same date shown for payment and the consideration described as not applicable, consistent with equity awards. Over the prior three months, the same seller completed several sales of common stock, including 501 shares on 12/09/2025 for $125,285.07, 501 shares on 12/02/2025 for $126,562.62, and other transactions ranging from 332 to 501 shares with gross proceeds between roughly $79,955.56 and $131,722.92.
VeriSign, Inc. executive Thomas C. Indelicarto, EVP, General Counsel & Secretary, reported an insider sale of company stock. On January 6, 2026, he sold 332 shares of VeriSign common stock at a price of $240.83 per share, as shown in the non-derivative securities table. After this transaction, he beneficially owned 31,277.0161 shares of VeriSign common stock, held directly.
VeriSign Inc. executive D. James Bidzos, who serves as Exec. Chairman, President and CEO and is also a director, reported multiple open-market sales of VeriSign common stock. The transactions took place on December 16–18, 2025, with individual sale lots ranging from 40 to 2,373 shares per trade.
Weighted average sale prices disclosed include $240.5487, $241.9918, $242.819, $243.5312, $244.5723, $245.2386, $244.145, $244.8968, $246.0645 and a single trade at $246.96 per share, each representing multiple underlying transactions within stated price ranges. After these sales, Bidzos directly beneficially owns 421,099.1378 shares of VeriSign common stock.
Verisign Inc. executive chairman, president and CEO D. James Bidzos reported multiple sales of Verisign common stock on December 9–11, 2025. The Form 4 lists several transactions coded as sales at weighted-average prices between $239.56 and $250.98 per share, with each price reflecting numerous trades within narrow ranges.
After these transactions, Bidzos directly beneficially owns 430,099.1378 shares of Verisign common stock. This amount includes 132.6549 dividend equivalent restricted stock units acquired on November 25, 2025 under the company’s Amended and Restated 2006 Equity Incentive Plan.
VeriSign, Inc. (VRSN) reported that long-time director Dr. Timothy Tomlinson, 75, has resigned from its Board of Directors for personal reasons related to his family and other business interests, effective November 21, 2025. The company highlighted his service since its founding in 1995, including leadership on the Audit Committee, which it credits with promoting a culture of compliance.
VeriSign stated that Dr. Tomlinson’s retirement did not result from any disagreement with the company on operations, policies, or practices. In connection with his retirement, the Board is expected to appoint a Lead Independent Director and decrease the overall size of the Board.